Junjie Xu

Sir Run Run Shaw Hospital, 3 East Qingchun Road
Hangzhou, 310016, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications

NAT10/ac4C drives intrahepatic cholangiocarcinoma by suppressing transposable elements via chromatin remodeling.

NAT10/ac4C drives intrahepatic cholangiocarcinoma by suppressing transposable elements via chromatin remodeling.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 14, 2026

Single-Cell and Bulk Transcriptomics Uncover the Cellular Ecosystem of Vascular Invasion in Intrahepatic Cholangiocarcinoma.

Single-Cell and Bulk Transcriptomics Uncover the Cellular Ecosystem of Vascular Invasion in Intrahepatic Cholangiocarcinoma.

Journal: Cells
Published: April 17, 2026

Systematic analysis identifies CDKN2A as a prognostic biomarker for hepatocellular carcinoma.

Systematic analysis identifies CDKN2A as a prognostic biomarker for hepatocellular carcinoma.

Journal: Discover oncology
Published: July 08, 2025

Erratum: cDCBLD2 mediates sorafenib resistance in hepatocellular carcinoma by sponging miR-345-5p binding to the TOP2A coding sequence: Erratum.

Erratum: cDCBLD2 mediates sorafenib resistance in hepatocellular carcinoma by sponging miR-345-5p binding to the TOP2A coding sequence: Erratum.

Journal: International journal of biological sciences
Published: July 03, 2025

Noninvasive prognostic classification of ITH in HCC with multi-omics insights and therapeutic implications.

Noninvasive prognostic classification of ITH in HCC with multi-omics insights and therapeutic implications.

Journal: Science advances
Published: May 02, 2025

Decoding cancer circulating transcriptomic signatures with language models.

Decoding cancer circulating transcriptomic signatures with language models.

Journal: Nature communications
Published: April 29, 2025

Correction: TR4 nuclear receptor suppresses HCC cell invasion via downregulating the EphA2 expression.

Correction: TR4 nuclear receptor suppresses HCC cell invasion via downregulating the EphA2 expression.

Journal: Cell death & disease
Published: February 13, 2025

A Novel MPT-Driven Necrosis-Related lncRNA Signature for Prognostic Prediction in Hepatocellular Carcinoma: Validation Using Organoids.

A Novel MPT-Driven Necrosis-Related lncRNA Signature for Prognostic Prediction in Hepatocellular Carcinoma: Validation Using Organoids.

Journal: Cancer medicine
Published: November 14, 2024

Alcaligenes faecalis induces intestinal T helper-17 cells by enhancing Rorc transcription through E3 ligase Trim21-mediated Fbxw7 degradation.

Alcaligenes faecalis induces intestinal T helper-17 cells by enhancing Rorc transcription through E3 ligase Trim21-mediated Fbxw7 degradation.

Journal: Immunity
Published: July 28, 2024

Synergistic Anticancer Strategy Targeting ECM Stiffness: Integration of Matrix Softening and Mechanical Signal Transduction Blockade in Primary Liver Cancers.

Synergistic Anticancer Strategy Targeting ECM Stiffness: Integration of Matrix Softening and Mechanical Signal Transduction Blockade in Primary Liver Cancers.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 22, 2024

Signaling pathways in liver cancer: pathogenesis and targeted therapy.

Signaling pathways in liver cancer: pathogenesis and targeted therapy.

Journal: Molecular biomedicine
Published: January 04, 2024

S100A6 drives lymphatic metastasis of liver cancer via activation of the RAGE/NF-kB/VEGF-D pathway.

S100A6 drives lymphatic metastasis of liver cancer via activation of the RAGE/NF-kB/VEGF-D pathway.

Journal: Cancer letters
Published: October 07, 2023
Showing 1-12 of 49

Last Updated: 09/26/2026